Telemonitoring of post chemotherapy symptoms with mobile devices: integrative literature review

Authors

DOI:

https://doi.org/10.33448/rsd-v10i10.19188

Keywords:

Telemonitoring; Oncology; Chemotherapy; Telemedicine; M-Health.

Abstract

The aim of this study was to assess whether there are benefits in telemonitoring post-chemotherapy symptoms with mobile devices compared to the traditional model of interval medical visits in the care of cancer patients, in order to provide gains in priority outcomes for the patient. This is an integrative review of articles published in Pubmed and Scielo in the last five years. Search terms included cancer, neoplasm, neoplasms, oncology, medical oncology, cancer care facilities, oncology service, telemedicine, telemonitoring, teleoncology, mobile health, mhealth, m-health, e-health, ehealth, video game, mobile game, mobile app, app-technology, chemotherapy, drug therapy, treatment, drug therapy. Randomized and controlled studies, published in English, cancer patients exposed to chemotherapy, remotely supervised from chemotherapy-induced acute toxicities, with data entered by mobile devices, were included. For data extraction, two reviewers used a form with standardized information fields. The studies analyzed after eligibility criteria point to better control of symptoms and outcomes. It is concluded that telemonitoring post-chemotherapy toxicity through mobile devices provides better symptom control and reduces complications.

Author Biography

Jemima Silva Inocêncio, Universidade Federal de Sergipe

Possui graduação em Enfermagem pela Universidade Tiradentes (2011). Pós-graduada em Enfermagem do Trabalho pela Faculdade Internacional de Curitiba (Especialização Lato Sensu ), Enfermagem em Emergência Intra e Pré-hospitalar pela Universidade Tiradentes (Especialização Lato Sensu ) e Enfermagem em Centro Cirúrgico e Central de Material pela faculdade Unyleya (Especialização Lato Sensu ). Mestranda em Gestão e Inovação Tecnológica em Saúde pela Universidade Federal de Sergipe. Enfermeira Assistencial do Centro Cirúrgico do Hospital Universitário da Universidade Federal de Sergipe pela Empresa Brasileira de Serviços Hospitalares - EBSERH.

References

Acs, B., Rantalainen, M., & Hartman, J. (2020). Artificial intelligence as the next step towards precision pathology. J Intern Med, 288(1), 62-81.

Alexander, M., Blum, R., Burbury, K., Coutsouvelis, J., Dooley, M., Fazil, O., Griffiths, T., Ismail, H., Joshi, S., 10, Love, N., Opat, S., Parente, P., Porter, N., Ross, E., Siderov, J., Thomas, P., White, S., Kirsa, S., & Rischin, D. (2017). Timely initiation of chemotherapy: a systematic literature review of six priority cancers - results and recommendations for clinical practice. Intern Med J, 47(1), 16-34.

Barlow, C. (2020). Oncology Research: Clinical Trial Management Systems, Electronic Medical Record, and Artificial Intelligence. Semin Oncol Nurs, 36(2), 151005.

Basch, E., Deal, A. M., Dueck, A. C., Scher, H. I., Kris, M. G., Hudis, C., & Schrag, D. (2017). Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. Jama, 318(2), 197-8.

Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., Chou, J. F., Dulko, D., Sit, L., Barz, A., Novotny, P., Fruscione, M., Sloan, J. A., & Schrag, D. (2016). Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial. J Clin Oncol, 34(6), 557-65.

Beatty, L., Koczwara, B., & Wade, T. (2016). Evaluating the efficacy of a self-guided Web-based CBT intervention for reducing cancer-distress: a randomised controlled trial. Support Care Cancer, 24(3), 1043-51.

Bera, K., Schalper, K. A., Rimm, D. L., Velcheti, V., & Madabhushi, A. (2019). Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology. Nat Rev Clin Oncol, 16(11), 703-15.

Bhavnani, S. P., Narula, J., & Sengupta, P. P. (2016). Mobile technology and the digitization of healthcare. Eur Heart J, 37(18), 1428-38.

Boulos, S. & Mazhar, D. (2017). The evolving role of chemotherapy in prostate cancer. Future Oncol, 13(12), 1091-5.

Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68(6), 394-424.

Brewer, J. R., Morrison, G., Dolan, M. E., & Fleming, G. F. (2016). Chemotherapy-induced peripheral neuropathy: Current status and progress. Gynecol Oncol, 140(1), 176-183.

Conforti, F., Pala, L., Bagnardi, V., Pas, T. D., Martinetti, M., Viale, G., Gelber, R. D., & Goldhirsch, A. (2018). Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis. Lancet Oncol, 19(6), 737-46.

Davis, S. N., O'malley, D. M., Bator, A., Ohman-Strickland, P., Clemow, L., Ferrante, J. M., Crabtree, B. F., Miller, S. M., Findley, P, & Hudson, S. V. (2019). Rationale and design of extended cancer education for longer term survivors (EXCELS): a randomized control trial of 'high touch' vs. 'high tech' cancer survivorship self-management tools in primary care. BMC Cancer, 19(1), 340.

De Calan, R. (2013). Medical empiricism from one myth to another. A critical reading of Foucault's Birth of Clinic. Gesnerus, 70(2), 193-210.

Denis, F., Basch, E., Septans, A. L., Bennouna, J., Urban, T., Dueck A. C., & Letellier, C. (2019). Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer. Jama, 321(3), 306-7.

Denis, F., Lethrosne, C., Pourel, N., Molinier, O., Pointreau, Y., Domont, J., Bourgeois, H., Senellart, H., Trémolières, P., Lizée, T., Bennouna, J., Urban, T., Khouri, C. E., Charron, A., Septans, A., Balavoine, M., Landry, S., Solal-Céligny, P., & Letellier, C. (2017). Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients. J Natl Cancer Inst, 109(9), sep 1.

Dolan, F. M. (2005). The paradoxical liberty of bio-power:Hannah Arendt and Michel Foucault on modern politics. Philosophy & Social Criticism, 31(3), 369-80.

Ejlertsen, B. (2016). Adjuvant chemotherapy in early breast cancer. Dan Med J, 63(5), b5222.

Eldeib, H. K., Abbassi, M. M., Hussein, M. M., Salem, S. E., & Sabry, N. A. (2019). The Effect of Telephone-Based Follow-Up on Adherence, Efficacy, and Toxicity of Oral Capecitabine-Based Chemotherapy. Telemed J E Health, 25(6), 462-70.

Farnell, D. A., Huntsman, D., & Bashashati, A. (2020). The coming 15 years in gynaecological pathology: digitisation, artificial intelligence, and new technologies. Histopathology, 76(1), 171-7.

Fox, P., Darley, A., Furlong, E., Miaskowski, C, Patiraki, E., Armes, J., Ream, E., Papadopoulou, C., McCann, L., Kearney, N., & Maguire, R. (2017). The assessment and management of chemotherapy-related toxicities in patients with breast cancer, colorectal cancer, and Hodgkin's and non-Hodgkin's lymphomas: A scoping review. Eur J Oncol Nurs, 26, 63-82.

Han, J. Y., Hawkins, R., Baker, T., Shah, D. V., Pingree, S., & Gustafson, D. H. (2017). How Cancer Patients Use and Benefit from an Interactive Cancer Communication System. J Health Commun, 22(10), 792-9.

Harada, K., Kaya, D. M., Shimodaira, Y., & Ajani, J. A. (2017). Global chemotherapy development for gastric cancer. Gastric Cancer, 20(suppl 1), 92-101.

Hellmann, M. D., Li, B. T., Chaft, J. E., & Kris, M. G. (2016). Chemotherapy remains an essential element of personalized care for persons with lung cancers. Ann Oncol, 27(10), 1829-35.

Huang, C. C., Kuo, H. P., Lin, Y. E., & Chen, S. C. (2019). Effects of a Web-based Health Education Program on Quality of Life and Symptom Distress of Initially Diagnosed Advanced Non-Small Cell Lung Cancer Patients: A Randomized Controlled Trial. J Cancer Educ, 34(1), 41-9.

Källander, K., Tibenderana, J. K., Akpogheneta, O. J., Strachan, D. L., Hill, Z., Asbroek, A. H. A., Conteh, L., Kirkwood, B. R., & Meek, S. R. (2013). Mobile health (mHealth) approaches and lessons for increased performance and retention of community health workers in low- and middle-income countries: a review. J Med Internet Res, 15(1), e17.

Kaplan, W. A. (2006). Can the ubiquitous power of mobile phones be used to improve health outcomes in developing countries? Global Health, 2, 9.

Kasi, P. M. & Grothey, A. (2016). Chemotherapy Maintenance. Cancer J, 22(3), 199-204.

Kim, H. J., Kim, S. M., Shin, H., Jang, J. S., Kim, Y. I., & Han, D. H. (2018). A Mobile Game for Patients With Breast Cancer for Chemotherapy Self-Management and Quality-of-Life Improvement: Randomized Controlled Trial. J Med Internet Res, 20(10), e273.

Kim, K. K., Bell, J. F., Bold, R., Davis, A., Ngo, V., Reed, S. C., & Joseph, J. G. (2016). A Personal Health Network for Chemotherapy Care Coordination: Evaluation of Usability Among Patients. Stud Health Technol Inform, 225, 232-6.

Kokts-Porietis, R. L., Stone, C. R., Friedenreich, C. M., Froese, A., McDonough, M. & McNeil, J. (2019). Breast cancer survivors' perspectives on a home-based physical activity intervention utilizing wearable technology. Support Care Cancer, 27(8), 2885-92.

Kruse, C. S.; Krowski, N.; Rodriguez, B.; Tran, L., Vela, J., & Brooks, M. (2017). Telehealth and patient satisfaction: a systematic review and narrative analysis. BMJ Open, 7(8), e016242.

Liu, G. F., Li, G. J., & Zhao, H. (2018). Efficacy and Toxicity of Different Chemotherapy Regimens in the Treatment of Advanced or Metastatic Pancreatic Cancer: A Network Meta-Analysis. J Cell Biochem, 119(1), 511-23.

Lynch, B. M., Nguyen, N. H., Moore, M. M., Reeves, M. M., Rosenberg, D. E., Boyle, T., Vallance, J. K., Milton, S., Friedenreich, C. M., & English, D. R. (2019). A randomized controlled trial of a wearable technology-based intervention for increasing moderate to vigorous physical activity and reducing sedentary behavior in breast cancer survivors: The ACTIVATE Trial. Cancer, 125(16), 2846-55.

Maldonado, J. M., Marques, A. B., & Cruz, A. (2016). Telemedicine: challenges to dissemination in Brazil. Cad Saude Publica, 32(suppl 2), e00155615.

Mangal, S., Gao, W., Li, T., & Zhou, Q. T. (2017). Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities. Acta Pharmacol Sin, 38(6), 782-97.

Mooney, K. H., Beck, S. L., Wong, B., Dunson, W., Wujcik, D., Whisenant, M., & Donaldson, G. (2017). Automated home monitoring and management of patient-reported symptoms during chemotherapy: results of the symptom care at home RCT. Cancer Med, 6(3), 537-46.

Phillips, M., Marsden, H., Jaffe, W., Matin, R. N., Wali, G. N., Greenhalgh, J., McGrath, E., James, R., Ladoyanni, E., Bewley, A., Argenziano, G., & Palamaras, I. (2019). Assessment of Accuracy of an Artificial Intelligence Algorithm to Detect Melanoma in Images of Skin Lesions. JAMA Netw Open, 2(10), e1913436.

Pillay, B., Wootten, A. C., Crowe, H., Corcoran, N., Tran, B., Bowden, P., Crowe, J., & Costello, A. J. (2016). The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature. Cancer Treat Rev, 42, 56-72.

Putora, P. M., Baudis, M., Beadle, B. M., El Naqa, I., Giordano, F. A., & Nicolay, N. H. (2020). Oncology Informatics: Status Quo and Outlook. Oncology, 98(6), 329-31.

Razvi, Y., Chan, S., McFarlane, T., McKenzie, E., Zaki, P., DeAngelis, C., Pidduck, W., Bushehri, A., Chow, E., & Jerzak, K. J. (2019). ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients. Support Care Cancer, 27(1), 87-95.

Reilly, C. M., Bruner, D. W., Mitchell, S. A., Minasian, L. M., Basch, E., Dueck, A. C., Cella, D., & Reeve, B. B. (2013). A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Support Care Cancer, 21(6), 1525-50.

Russell, L., Pascoe, M. C., Seymour, J. F., Aranda, S., Butow, P., Gough, K., & Schofield, P. (2019). The trials and tribulations of conducting an m-health pilot randomized controlled trial to improve oral cancer therapy adherence: recommendations for future multisite, non-drug clinical trials. BMC Res Notes, 12(1), 226.

Sen, M. & Prestwich, R. (2016). Chemotherapy and Targeted Therapy. Adv Otorhinolaryngol, 78, 148-156.

Shimizu, H. & Nakayama, K. I. (2020). Artificial intelligence in oncology. Cancer Sci, 111(5), 1452-60.

Silva, B. M., Rodrigues, J. J., De La Torre Díez, I., López-Coronado, M., & Saleem, K. (2015). Mobile-health: A review of current state in 2015. J Biomed Inform, 56, 265-72.

Sirintrapun, S. J. & Lopez, A. M. (2018). Telemedicine in Cancer Care. Am Soc Clin Oncol Educ Book, 38, 540-5.

Smith, K. M. (2008). Building upon existing evidence to shape future research endeavors. Am J Health Syst Pharm, 65(18), 1767-74.

Souza, M. T., Silva, M. D., & Carvalho, R. Revisão integrativa: o que é e como fazer. Einstein (São Paulo), 8(1), 102-6.

Torre, L. A., Siegel, R. L., Ward, E. M., & Jemal, A. (2016). Global Cancer Incidence and Mortality Rates and Trends--An Update. Cancer Epidemiol Biomarkers Prev, 25(1), 16-27.

Tseng, H. H., Wei, L., Cui, S., Luo, Y., Ten Haken, R. K., & El Naga, I. (2020). Machine Learning and Imaging Informatics in Oncology. Oncology, 98(6), 344-62.

Wallis, C. J. D., Saskin, R., Choo, R., Herschorn, S., Kodama, R. T., Satkunasivam, R., Shah, P. S., Danjoux, C., & Nam, R. K. (2016). Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol, 70(1), 21-30.

Wang, S., Yang, D. M., Rong, R., Zhan, X., Fujimoto, J., Liu, H., Minna, J., Wistuba, I. I., Xie, Y, & Xiao, G. (2019). Artificial Intelligence in Lung Cancer Pathology Image Analysis. Cancers (Basel), 11(11), 1673.

Watson, N. L., Mull, K. E., Heffner, J. L., Mcclure, J. B., & Bricker, J. B. (2018). Participant Recruitment and Retention in Remote eHealth Intervention Trials: Methods and Lessons Learned From a Large Randomized Controlled Trial of Two Web-Based Smoking Interventions. J Med Internet Res, 20(8), e10351.

Worster, B. & Swartz, K. (2017). Telemedicine and Palliative Care: an Increasing Role in Supportive Oncology. Curr Oncol Rep, 19(6), 37.

Yount, S. E.; Rothrock, N.; Bass, M.; Beaumont, J. L., Pach, D., Lad, T., Patel, J., Corona, M., Weiland, R., Ciello, K. D., & Cella, D. (2014). A randomized trial of weekly symptom telemonitoring in advanced lung cancer. J Pain Symptom Manage, 47(6), 973-89.

Downloads

Published

20/08/2021

How to Cite

MOURA, E. T. A.; INOCÊNCIO, J. S.; SANT’ANA, A. da S. .; OLIVEIRA, A. A. de .; SIMÕES, S. de M. . Telemonitoring of post chemotherapy symptoms with mobile devices: integrative literature review. Research, Society and Development, [S. l.], v. 10, n. 10, p. e586101019188, 2021. DOI: 10.33448/rsd-v10i10.19188. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/19188. Acesso em: 24 apr. 2024.

Issue

Vol. 10 No. 10

Section

Health Sciences

License

Copyright (c) 2021 Eduardo Tadeu Azevedo Moura; Jemima Silva Inocêncio; André da Silva Sant’Ana; Adicinéia Aparecida de Oliveira; Silvia de Magalhães Simões

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.